Complicated Outcome Prediction After Liver Resection

Although mortality after liver surgery reduced during the last three decades to less than 2%, post-operative course is still complicated in a range of 20-50% of cases.The identification of one or few factors which could detect the real risk of complicated post-operative outcome, may help anesthesiologist to decide whether admit a patient to ICU or not.The primary aim of this study was to evaluate whether RRI, alone or along with other items, can predict post-operative complication after hepatic resection.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Liver Neoplasms Digestive System Diseases Digestive System Neoplasms Liver Diseases Neoplasms Neoplasms by Site

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients resectable and affected by primary and secondary liver disease

Exclusion criteria

Subjects affected by kidney disease and/or cirrhosis and pregnant patients were excluded from the trial. Patients who should have needed nephrectomy during the operation would be also excluded.

Treatment and study plan

Liver resection for primary and secondary disease

Procedure

Liver resection in parenchyma-sparing setting for primary and secondary disease

Primary outcomes

renal resistive index (RRI)

Time frame: up to 7 days after surgery

the association between RRI and occurrence of hepatic complications during the first postoperative week.

Sponsors and collaborators

Lead sponsor

University of Milan

Other

Registry information

Official study title

Complicated Outcome Prediction After Liver Resection: the Role of Renal Resistive Index

Important dates

Study start: 2015
Primary completion: 2017
Study completion: 2017
First posted: Jul 5, 2018
Registry last updated: Jul 5, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed